This intervention was initiated at the T-1 timepoint, coinciding with the observation of white adipose tissue atrophy and elevated expression of GRP75 and UCP1 in YES2 tumour-bearing mice (Fig. 6e). This evidence concerns the gene HSPA9 and neoplasm.